Genetic Abnormalities inFOXP1Are Associated with Congenital Heart Defects


    loading  Checking for direct PDF access through Ovid

Abstract

The etiology for the majority of congenital heart defects (CHD) is unknown. We identified a patient with unbalanced atrioventricular septal defect (AVSD) and hypoplastic left ventricle who harbored an ∽0.3 Mb monoallelic deletion on chromosome 3p14.1. The deletion encompassed the first four exons of FOXP1, a gene critical for normal heart development that represses cardiomyocyte proliferation and expression of Nkx2.5. To determine whether FOXP1 mutations are found in patients with CHD, we sequenced FOXP1 in 82 patients with AVSD or hypoplastic left heart syndrome. We discovered two patients who harbored a heterozygous c.1702C>T variant in FOXP1 that predicted a potentially deleterious substitution of a highly conserved proline (p.Pro568Ser). This variant was not found in 287 controls but is present in dbSNP at a 0.2% frequency. The orthologous murine Foxp1 p.Pro596Ser mutant protein displayed deficits in luciferase reporter assays and resulted in increased proliferation and Nkx2.5 expression in cardiomyoblasts. Our data suggest that haploinsufficiency of FOXP1 is associated with human CHD.We identified a patient with complex congenital heart disease (CHD) who harbored a heterozygous deletion of FOXP1 and subsequently found two patients with CHD who had a heterozygous c.1702C>T variant that predicted a potentially deleterious mutation (p.P568S). The mutant Foxp1 displayed functional deficits in cell-based assays suggesting that FOXP1 mutations are associated with CHD.

    loading  Loading Related Articles